Xylem Number of Exercisable Options increased by 9.9% to 896K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.0%, from 905K to 896K. This increase may warrant attention — for this metric, lower values are generally preferred.
A high number indicates significant potential for future share issuance and dilution as employees exercise their vested options.
This metric counts the number of share-based payment options that have vested and are currently available for employees...
Standard disclosure in equity compensation footnotes for all public companies.
options_exercisable_number| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 1.4M | 1.3M | 1.4M | 1.4M | 1.4M | 1.5M | 2M | 2M | 1.3M | 859K | 829K | 905K | 863K | 815K | 896K |
| QoQ Change | — | -9.2% | +11.3% | +0.5% | -3.1% | +7.8% | +32.4% | -1.3% | -35.8% | -31.5% | -3.5% | +9.2% | -4.6% | -5.6% | +9.9% |
| YoY Change | — | — | — | +1.6% | +8.4% | +4.9% | +38.2% | +40.8% | -16.1% | -56.6% | -57.6% | -27.8% | +0.5% | -1.7% | -1.0% |